Skip to main content
TipRanks
Go Ultimate75% OFF

Chi Sheng Pharma & Biotech Co., Ltd. (4111) Cash flow

Chi Sheng Pharma & Biotech Co., Ltd. Cash Flow

TW:4111's free cash flow for Q2 2026 was NT$58.84M. For the 2026 fiscal year, TW:4111's free cash flow was decreased by NT$-32.49M and operating cash flow was NT$91.33M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 409.05MNT$ 213.20MNT$ 74.52MNT$ 214.86MNT$ 139.33M
NT$ -97.17MNT$ -86.31MNT$ -76.61MNT$ 63.24MNT$ -289.02M
NT$ -204.17MNT$ -171.75MNT$ -73.11MNT$ -74.88MNT$ 66.68M
NT$ 443.91MNT$ 336.19MNT$ 381.05MNT$ 456.25MNT$ 252.27M
NT$ 315.19MNT$ 127.98MNT$ -26.98MNT$ 109.00MNT$ -126.18M

Currency in TWD

Chi Sheng Pharma & Biotech Co., Ltd. Cash Flow

-400M-200M0200M400M600M2019202020212022202320242025OperatingInvestingFinancing